Egide (ALGID) H2 2024 earnings summary

Executive summary

• Revenue declined 18% year-over-year to €30.04M, reflecting reduced orders, geopolitical impacts, and supply chain disruptions across all entities.

• EBITDA improved by 52% to -€0.49M, demonstrating the effectiveness of restructuring and operational optimization.

• Net loss narrowed by 19% to -€2.48M, with notable improvement at Santier, though all entities remain unprofitable.

Financial highlights

• Revenue: €30.04M in 2024, down from €36.71M in 2023 (-18%).

• EBITDA: -€0.49M, improved from -€1.02M in 2023.

• Operating loss reduced to -€1.95M from -€2.74M in 2023.

• Net loss: -€2.48M, down from -€3.07M in 2023.

• Cash position decreased to €1.85M from €3.20M.

Outlook and guidance

• Anticipates revenue growth in 2025, supported by stronger order intake and opportunities in Defense and Aerospace.

• Plans to modernize industrial tools and continue diversification.

• Monitoring geopolitical and tariff risks, but does not expect significant negative impact in 2025.

• Longer-term opportunities expected from increased defense budgets and strategic investments from 2026-2027.